share_log

Kala Pharmaceuticals Q3 EPS $(3.41) Misses $(2.15) Estimate

Kala Pharmaceuticals Q3 EPS $(3.41) Misses $(2.15) Estimate

卡拉制药第三季度每股收益(3.41 美元)未达美元(2.15)预期
Benzinga ·  2023/11/13 08:11

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(3.41) per share which missed the analyst consensus estimate of $(2.15) by 58.6 percent. This is a 61.77 percent increase over losses of $(8.92) per share from the same period last year.

卡拉制药(纳斯达克股票代码:KALA)公布季度每股亏损3.41美元,比分析师共识估计的2.15美元(2.15美元)低58.6%。这比去年同期每股亏损8.92美元(8.92美元)增加了61.77%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发